2014 Hemostasis Gordon Research Conference and Gordon Research Seminar

描述(由申请人提供)： 我们请求部分支持止血戈登研究研讨会(GRS)和戈登研究会议(GRC)，该研讨会将于2014年7月26日至8月1日在NH沃特维尔山谷的GRC网站举行。GRC止血会议始于1973年，此后每两年举行一次。2014年会议是该系列会议中的第32次会议，被认为是止血研究的首场会议。在2014年止血GRC会议之前，将举行一次GRS会议，专门讨论学员的发展和接触。GRS会议由受训人员组织和管理，非常成功，并提高了受训人员在GRC的形象。止血GRS/GRC汇集了对血小板和凝血蛋白的生物、生化和遗传学感兴趣的科学家、参与治疗出血和血栓性疾病的医生以及来自小型和大型制药公司的研究人员，他们正在开发止血疾病的新疗法。这次会议具有传奇般的地位，使其成为展示尖端研究和揭示该领域重大进展的论坛。事实上，最近在止血方面最引人注目的一些成就是在本系列的前几次会议上首次公布的，或者是由这次会议促进的协作互动推动的。已同意参加GRS和GRC的特邀演讲者和讨论领导者名单令人印象深刻，他们代表了该领域的顶级调查人员。这些演讲者和讨论领袖将增强环境对所有与会者，特别是初级与会者的刺激性。 调查员和实习生。与以前的会议相比，2014年的止血GRS和GRC项目包括更多的女性、少数族裔和年轻研究人员的参与。此外，2014年的会议将包括相当数量的与会者，他们是初级教职员工、学生、博士后研究员和肢体残疾人士。2014年 止血GRS计划包括一位非常成功的女内科科学家简·弗里德曼博士的主旨演讲，来自实习生的12次演讲，以及40张海报讨论。2014年止血GRC项目将有4个海报聚会和8个演讲环节，包括：1.血栓和凝血中的血管壁；2.感染过程中的血栓和凝血；3.发育和疾病中的血小板和凝血因子；4.血管环境中的串扰；5.血栓、凝血和炎症之间的联系；6.疾病中的凝血和血小板；7.热点话题摘要，其中8名学员介绍了他们的工作；8.有缺陷的止血。会议将于8月1日晚结束，主题为“老鼠和人类遗传学对血栓形成和止血的影响”。

DESCRIPTION (provided by applicant): We request partial support for the Hemostasis Gordon Research Seminar (GRS) and Gordon Research Conference (GRC), which will be held at the GRC site in Waterville Valley, NH, July 26th through August 1st, 2014. The GRC meeting on hemostasis began in 1973 and has been held biennially since then. The 2014 conference represents the 32nd meeting in the series and is considered the premiere meeting for hemostasis-based research. The 2014 Hemostasis GRC meeting will be preceded by a GRS meeting dedicated to trainee development and exposure. The GRS meeting is organized and run by trainees, is highly successful, and enhances the profile of trainees at the GRC. The Hemostasis GRS/GRC brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have agreed to participate in the GRS and GRC is impressive and represents top investigators in the field. These speakers and discussion leaders will enhance the stimulating nature of the environment for all attendees, especially junior investigators and trainees. The 2014 Hemostasis GRS and GRC programs include heightened participation from women, minorities, and young investigators compared to previous conferences. Moreover, the 2014 meeting will include a significant number of attendees who are junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The 2014 Hemostasis GRS program includes a keynote presentation from Dr. Jane Freedman, a very successful female physician-scientist, 12 presentations from trainees, and 40 poster discussions. The 2014 Hemostasis GRC program will have 4 poster gatherings and 8 presentation sessions that include: 1. The Vessel Wall in Thrombosis and Coagulation; 2. Thrombosis and Coagulation During Infection; 3. Platelets and Coagulation Factors in Development and Disease; 4. Crosstalk in the Vascular Milieu; 5. Links Between Thrombosis, Coagulation, and Inflammation; 6. Coagulation and Platelets in Disease; 7. Hot Topic Abstract Talks where 8 trainees present their work; and, 8. Defective Hemostasis. The conference will end on the evening of August 1st with a keynote session entitled "The Impact of Mouse and Human Genetics on Thrombosis and Hemostasis".